Margaret Hamburg
Search results
Andrew C. von Eschenbach (born October 30, 1941) was the Commissioner of the United States Food and Drug Administration from 2006 to 2009. He became acting Commissioner on September 26, 2005, after the resignation of his predecessor Lester Crawford , and was confirmed as Commissioner by the Senate on December 7, 2006.
Andrew C. von Eschenbach, MD, currently serves as President of Samaritan Health Initiatives, Inc. and as an Adjunct Professor at University of Texas MD Anderson Cancer Center. He served as the 20th Commissioner of Food and Drugs (2005-09) where he championed an agenda to modernize the FDA.
May 6, 2021 · The 2021 Pontifical Hero Award for Inspiration. for leadership in bridging the gap between science and faith. There are few people who embody the intersection of science, faith and public service more than Dr. Andrew von Eschenbach. As a world-renowned urologist, president of the American Cancer Society, head of the National Cancer Institute ...
Dr. Andrew von Eschenbach. Andrew C. von Eschenbach is an advisor and former chairman of the Manhattan Institute’s Project FDA. In 2005–09, he was commissioner of the U.S. Food and Drug Administration, where he championed an agenda to modernize the FDA. Von Eschenbach joined the FDA after four years as director of the National Cancer ...
Andrew C. von Eschenbach, M.D., was appointed Acting Commissioner of Food and Drugs in September 2005, where he immediately engaged an agenda to modernize the FDA. Under his leadership, many...
Apr 8, 2020 · If he were back at his old job at FDA, von Eschenbach would favor a multi-pronged approach to deal with the current crisis: capitalize on big data sets and near-instantaneous transfers; translate successful cancer immunotherapies and apply them to viruses; accelerate testing of drugs that have already been FDA-approved; and foster greater ...
Senior Advisor. In his role as Senior Advisor, Dr. von Eschenbach provides strategic counsel on regulatory and public affairs, clinical trial development, and other critical corporate matters. Dr. von Eschenbach is widely recognized as a leading physician, surgeon, oncologist, and executive.
